OverviewChartNewsTraderScreen

BNP Paribas Knock-Out A2A/  DE000PN4E845  /

EUWAX
7/10/2024  8:23:18 AM Chg.0.000 Bid10:00:40 PM Ask10:00:40 PM Underlying Strike price Expiration date Option type
0.440EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 A2A 1.4517 EUR 12/31/2078 Call
GlobeNewswire 5/10 iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire 5/6 Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 3/19 Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financ...
Newsfile Corp 3/8 Noda Presents Report on Key Payment Trends: Diverse PaymentMethods, AI, and More
GlobeNewswire 3/6 iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire 1/8 iTeos Announces 2024 Strategic Priorities and Anticipated Milestones
GlobeNewswire 11/28/2023 Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update
GlobeNewswire 11/7/2023 Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire 11/7/2023 iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
GlobeNewswire 11/6/2023 Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...
Newsfile Corp 10/4/2023 Noda and Tickets Travel Network Forge Partnership for Seamless Travel Payments
GlobeNewswire 9/21/2023 Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice Preside...
GlobeNewswire 9/20/2023 Innovative Payment Solutions Announces Funding of Second $500,000 Capital Contribution to IPSIPay Ex...
GlobeNewswire 9/5/2023 Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagon...
GlobeNewswire 8/30/2023 Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update
GlobeNewswire 3/10/2022 Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financ...
GlobeNewswire 3/3/2022 Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Finan...
GlobeNewswire 2/10/2022 Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021
GlobeNewswire 2/2/2022 Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer
GlobeNewswire 1/14/2022 Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial o...
GlobeNewswire 1/3/2022 iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/9/2021 iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology...
GlobeNewswire 11/12/2021 Corvus Pharmaceuticals Presents Updated Data from Mupadolimab (Anti-CD73) Phase 1/1b Clinical Trial ...
GlobeNewswire 11/10/2021 Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
GlobeNewswire 11/3/2021 iTeos to Report Third Quarter 2021 Financial Results on November 10, 2021